UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
July 9, 2026 4:05 P.M.
Form:
S-3
CIK:
0001386570
Company Name:
Niagen Bioscience, Inc.
File Number:
333-297093